Larvol Delta - WPD-Pharmaceuticals-Reports-Active-Compound-in-Licensed-Drug-Candidate-Reduces-Coronavirus-Replication-in-Vitro-by-100

WP1122 - WPD Pharma, Moleculin, CNS Pharma

http://www.globenewswire.com/news-release/2020/04/09/2014074/0/en/WPD-Pharmaceuticals-Reports-Active-Compound-in-Licensed-Drug-Candidate-Reduces-Coronavirus-Replication-in-Vitro-by-100.html

Apr 9, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next